Yahoo Finance • 3 months ago
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is t... Full story
Yahoo Finance • 4 months ago
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Catalent (CTLT). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to ta... Full story
Yahoo Finance • 4 months ago
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.... Full story
Yahoo Finance • 5 months ago
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. For example, the United Therapeutics... Full story
Yahoo Finance • 9 months ago
On January 18, 2024, EVP & GENERAL COUNSEL Paul Mahon sold 6,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing. United Therapeutics Corp is a biotechnology company focused on the development and commer... Full story
Yahoo Finance • 10 months ago
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is Unite... Full story
Yahoo Finance • 11 months ago
United Therapeutics Corp (NASDAQ:UTHR) has recently witnessed an insider sell that has caught the attention of investors and market analysts. Director Christopher Causey sold 3,000 shares of the company on December 12, 2023. This transacti... Full story
Yahoo Finance • 12 months ago
United Therapeutics Corp (NASDAQ:UTHR) has recently witnessed a significant insider sell that has caught the attention of investors and market analysts. Paul Mahon, the company's EVP & General Counsel, sold 6,000 shares of the company on N... Full story
Yahoo Finance • 12 months ago
In this article, we will be taking a look at the top 20 drug companies in the US by revenue. To skip our detailed analysis, you can go directly to see the Top 5 Drug Companies in the US by Revenue. Following the Covid-19 pandemic, which d... Full story
Yahoo Finance • last year
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. and EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today a definitive agreeme... Full story
Yahoo Finance • last year
In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into. If you want to skip our introduction to the biotechnology industry and how it might be affected by recent economic and stock market t... Full story
Yahoo Finance • last year
In this article, we discuss billionaire Jim Simons’ top 15 stock picks in 2023. If you want to see more stocks in this selection, check out Billionaire Jim Simons' 2023 Portfolio: Top 5 Stock Picks. Managed by Renaissance Technologies, th... Full story
Yahoo Finance • 2 years ago
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 26, 2023--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2023 financial results before the market opens on Wedn... Full story
Yahoo Finance • 2 years ago
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Unfortunately, these... Full story
Yahoo Finance • 2 years ago
In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story
Yahoo Finance • 2 years ago
Don’t get fooled into thinking the stock market’s recent positive action has legs. Morgan Stanley’s Chief U.S. Equity Strategist Mike Wilson thinks it’s time to take profits “before the Bear returns in earnest.” Wilson notes that his team... Full story
Yahoo Finance • 2 years ago
New company will leverage 3D Systems’ recent breakthroughs in bioprinting of vascularized human organs and tissues to accelerate new drug development, reduce costs, and ultimately reduce or eliminate the need for animal testingUnique biopr... Full story
Yahoo Finance • 2 years ago
Many stocks showing relative strength now hail from the medical sector. Here's a swing trading example with UTHR stock.... Full story
Yahoo Finance • 2 years ago
Stocks turned mixed as Fed chief Jerome Powell minimized recession risks before Congress. But crude oil and bond yields tumbled.... Full story
Yahoo Finance • 2 years ago
The Dow Jones fell while crude oil and bond yields tumbled even as Fed chief Jerome Powell minimized recession risks before Congress.... Full story